Found 39 results
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is V  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
V
J. M. Vose, Carter, S., Burns, L. J., Ayala, E., Press, O. W., Moskowitz, C. H., Stadtmauer, E. A., Mineshi, S., Ambinder, R., Fenske, T., Horowitz, M., Fisher, R., and Tomblyn, M., Phase III randomized study of rituximab/carmustine, etoposide, cytarabine, and melphalan (BEAM) compared with iodine-131 tositumomab/BEAM with autologous hematopoietic cell transplantation for relapsed diffuse large B-cell lymphoma: results from the BMT C, J Clin Oncol, vol. 31, no. 13, pp. 1662-8, 2013.
A. Vora, SanGiovanni, J. P., Chew, E. Y., Ajudua, S. N., Reed, G. F., Agron, E., Henning, A. K., Clemons, T. E., Hoh, J., and Elashoff, M., Single Marker Associations of Cell Cycle Pathway Genes with Advanced AMD, in Annual Meeting, Association for Research in Vision and Ophthalmology (ARVO), Fort Lauderdale, FL, 2007.
S. Vitale, Agrón, E., Clemons, T. E., Keenan, T. D. L., Domalpally, A., Danis, R. P., and Chew, E. Y., Association of 2-Year Progression Along the AREDS AMD Scale and Development of Late Age-Related Macular Degeneration or Loss of Visual Acuity: AREDS Report 22., JAMA Ophthalmol, 2020.
S. Vitale, Clemons, T. E., Agrón, E., Ferris, F. L., Domalpally, A., Danis, R. P., and Chew, E. Y., Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10., JAMA Ophthalmol, vol. 134, no. 9, pp. 1041-7, 2016.
L. Vignati, Sheetz, M. J., Girach, A., Zhi, X., Davis, M. D., Milton, R. C., and Group, Afor the P. K., Effect of the oral protein kinase C b Inhibitor, Ruboxistaurin, on visual acuity in the PKC-DRS2 Study, 2006.
A. Vigano, Dally, L., Bricalli, D., Sala, N., Pirillo, M., Saresella, M., Trabattoni, D., Vella, S., Clerici, M., and Principi, N., Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection, J Pediatric, vol. 135, pp. 675-82, 1999.
A. Vigano, Vella, S., Saresella, M., Vanzulli, A., Bricalli, D., Di Fabio, S., Ferrante, P., Andreotti, M., Pirillo, M., Dally, L. G., Clerici, M., and Principi, N., Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume., AIDS, vol. 14, no. 3, pp. 251-61, 2000.
A. Vigano, Vella, S., Saresella, M., Vanzulli, A., Bricalli, D., Di Fabio, S., Ferrante, P., Andreotti, M., Pirillo, M., Dally, L. G., Clerici, M., and Principi, N., Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume, AIDS Res HumRetroviruses, vol. 14, pp. 251-61, 2000.
A. Vigano, Dally, L., Bricalli, D., Sala, N., Pirillo, M., Saresella, M., Trabattoni, D., Vella, S., Clerici, M., and Principi, N., Clinical and immuno-virologic characterization of the efficacy of stavudine, lamivudine, and indinavir in human immunodeficiency virus infection., J Pediatr, vol. 135, no. 6, pp. 675-82, 1999.
L. E. Via, Gore-Langton, R. E., and Pluda, J. M., Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416, Oncology, vol. 14, pp. 13121315-16 1321-23, 2000.
L. E. Via, Gore-Langton, R. E., and Pluda, J. M., Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416., Oncology (Williston Park), vol. 14, no. 9, pp. 1312, 1315-6, 1321-3, 2000.
D. A. Vena, Collie, D., Wu, H., Gibbs, J. L., Broder, H. L., Curro, F. A., Thompson, V. P., and Craig, R. G., Prevalence of persistent pain 3 to 5 years post primary root canal therapy and its impact on oral health-related quality of life: PEARL Network findings., J Endod, vol. 40, no. 12, pp. 1917-21, 2014.
S. Vella, Floridia, M., Dally, L. G., Tomino, C., Fragola, V., Weimer, L. E., Milazzo, F., Mazzotta, F., Moroni, M., Pastore, G., Scalise, G., Sinicco, A., Ortona, L., De Rienzo, B., and Dianzani, F., A randomized trial (ISS 901) of switching to didanosine versus continued zidovudine after the diagnosis of AIDS., J Acquir Immune Defic Syndr Hum Retrovirol, vol. 12, no. 5, pp. 462-9, 1996.
A. Veitz-Keenan, Barna, J. Ann, Strober, B., Matthews, A. G., Collie, D., Vena, D., Curro, F. A., and Thompson, V. P., Treatments for hypersensitive noncarious cervical lesions: a Practitioners Engaged in Applied Research and Learning (PEARL) Network randomized clinical effectiveness study., J Am Dent Assoc, vol. 144, no. 5, pp. 495-506, 2013.
A. Veitz-Keenan, Barna, J. A., Strober, B., Matthews, A. G., Collie, D., Vena, D., Curro, F. A., and Thompson, V. P., Treatments for Hypersensitive Noncarious Cervical Lesions: A Practitioners Engaged in Applied Research and Learning (PEARL) Network Randomized Clinical Effectiveness Study, J Am Dent Assoc, vol. 144, pp. 495-506, 2013.
M. Veerappan, El-Hage-Sleiman, A. - K. M., Tai, V., Chiu, S. J., Winter, K. P., Stinnett, S. S., Hwang, T. S., G Hubbard, B., Michelson, M., Gunther, R., Wong, W. T., Chew, E. Y., and Toth, C. A., Optical Coherence Tomography Reflective Drusen Substructures Predict Progression to Geographic Atrophy in Age-related Macular Degeneration., Ophthalmology, vol. 123, no. 12, pp. 2554-2570, 2016.
A. Vats, Donaldson, L. A., Fine, R. N., and Chavers, B., Outcome of renal transplantation in North American children on peritoneal dialysis: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRCTS), 1999.
S. Vasan, Hurley, A., Schlesinger, S. J., Hannaman, D., Gardiner, D. F., Dugin, D. P., Boente-Carrera, M., Vittorino, R., Caskey, M., Andersen, J., Huang, Y., Cox, J. H., Tarragona-Fiol, T., Gill, D. K., Cheeseman, H., Clark, L., Dally, L., Smith, C., Schmidt, C., Park, H. H., Kopycinski, J. T., Gilmour, J., Fast, P., Bernard, R., and Ho, D. D., In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers., PLoS One, vol. 6, no. 5, p. e19252, 2011.
S. Vasan, Schlesinger, S., Huang, Y., Hurley, A., Lombardo, A., Chen, Z., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Clark, L., Dugin, D., Schmidt, C., Song, Y., Seamons, L., Dally, L., Ho, M., Smith, C., Markowitz, M., Cox, J., Gill, D., and Gilmour, J., Phase 1 Safety and Immunogenicity Evaluation of ADVAX a Multigenic, DNA-Based Clade C/B’ HIV-1 Candidate Vaccine, PLoS ONE, vol. 5, p. e8617, 2010.
S. Vasan, Schlesinger, S., Chen, Z., Hurley, A., Lombardo, A., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Clark, L., Dugin, D., Boente-Carrera, M., Schmidt, C., Fang, Q., Ba, L., Huang, Y., Zaharatos, G., Gardiner, D., Caskey, M., Seamons, L., and Ho, M., Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 Clade B'/C Candidate Vaccine, PLOS One, vol. 5, p. e8816, 2010.
S. Vasan, Schlesinger, S. J., Huang, Y., Hurley, A., Lombardo, A., Chen, Z., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Clark, L., Dugin, D., Schmidt, C., Song, Y., Seamons, L., Dally, L., Ho, M., Smith, C., Markowitz, M., Cox, J., Gill, D. K., Gilmour, J., Keefer, M. C., Fast, P., and Ho, D. D., Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine., PLoS One, vol. 5, no. 1, p. e8617, 2010.
S. Vasan, Schlesinger, S. J., Chen, Z., Hurley, A., Lombardo, A., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Clark, L., Dugin, D., Boente-Carrera, M., Schmidt, C., Fang, Q., Huang, Y., Zaharatos, G. J., Gardiner, D. F., Caskey, M., Seamons, L., Ho, M., Dally, L., Smith, C., Cox, J., Gill, D., Gilmour, J., Keefer, M. C., Fast, P., and Ho, D. D., Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine., PLoS One, vol. 5, no. 1, p. e8816, 2010.
S. Vasan, Schlesinger, S. J., Chen, Z., Hurley, A., Than, S., Adesanya, P., Bunce, C., Boaz, M., Boyle, R., Sayeed, E., Gardiner, D. F., Zaharatos, G. J., Caskey, M., Q, F., Schmidt, C., Huang, Y., Seamons, L., Ho, M., Lombardo, A., Gilmour, J., Keefer, M. C., Fast, P., and Ho, D. D., Cellular and Humoral Immunogenicity of ADMVA, a Clade C/B MVA-Based HIV-1 Candidate Vaccine, in Healthy Volunteers, in AIDS Vaccine 2007 Conference, Seattle, WA, 2007.
J. Varni, Limbers, C., Sorensen, L., Neighbors, K., Martz, K., Bucuvalas, J., and Alonso, E., PedsQL™ Cognitive Functioning Scale in Pediatric Liver Transplant Recipients: Feasibility, Reliability, and Validity, Qual Life Res, vol. 20, pp. 913-921, 2011.
J. W. Varni, Limbers, C. A., Sorensen, L. G., Neighbors, K., Martz, K., Bucuvalas, J. C., and Alonso, E. M., PedsQL™ Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity., Qual Life Res, vol. 20, no. 6, pp. 913-21, 2011.